Definitive Contract 75N91021C00005
Award Date
1/22/21
Potential Completion Date
12/21/23
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Cell Microsystems Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Cell Microsystems Inc., a small business manufacturer of tools for imaging, sorting, and isolating single cells and colonies. The $2,295,432.00 contract, which is part of the Small Business Innovation Research (SBIR) program, supports the integration of Cell Microsystems' SCOPE SEQ technology with air flow capabilities for the molecular analysis of glioblastoma, an aggressive...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Cell Microsystems Inc., a for-profit manufacturer of biomedical research equipment and supplies. The $205,600.00 contract is for the delivery of the CELLRAFT air system and CYTOSORT 100 instrument, which support various research applications such as gene editing, cancer research, and immunology. The contract does not have a set-aside designation. Cell...
This federal contract award is for the procurement of a Celigo S Imaging Cytometer System from Nexcelom Bioscience LLC, a for-profit limited liability company that develops and markets image cytometry products for life science and biomedical research. The contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), for $115,000.00 on a firm fixed-price basis. The original solicitation was...
This is a $5,367,461.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for research related to the "Underlying Pharmacology of Brain Tumor Drug Treatment Response and Failure." It has a completion date of September 23, 2023. The contract does not have a set-aside designation. Leidos Biomedical Research, as the...
This is a $100,000.00 firm fixed price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Nanocellect Biomedical Inc., a small business, for a small sized cell sorter with single cell dispenser. The award was made on August 6, 2018 with an ultimate completion date of August 5, 2019. Nanocellect Biomedical has provided cell sorting systems and related services to various federal agencies, and this contract supports the company's...
This is a $189,094.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Angiocrine Bioscience, Inc., a for-profit organization. The contract is for the "SBIR PHASE I LARGE SCALE PROPAGATION OF CANCER CELLS USING THE VERAVEC PLATFORM IN AN AUTOMATED CLOSED SYSTEM" and was set aside for small businesses. The contract has an ultimate completion date of July 21, 2016 and was awarded on September 22, 2015. This appears to be a Small Business...
This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Cancer Institute (NCI) to Nexcelom Bioscience LLC, a small business, for a Celigo Image Cytometer System. The $159,000 contract supports the NCI's Transplantation Therapy Section within the Experimental Transplantation and Immunology Branch, which focuses on research related to T cell homeostasis, repertoire, function, and regeneration in a transplantation setting. The Celigo system will...
This is a $198,641 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Nanocellect Biomedical Inc., a for-profit biotechnology company. The contract is for the development of a "CTC Label and Capture by Lab-on-a-Chip Flow-Cytometry" solution, which aligns with the NCI's research interests. Nanocellect Biomedical is an innovative provider of automated cell analysis, sorting, and dispensing equipment and services, with a strong...
This is a $1,648,645.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc. under the Small Business Innovation Research (SBIR) Phase II program. The purpose of this contract is to focus on developing a T-cell activation protocol consistent with reporter cell viability, creating a proprietary reporter cell line, and gathering and benchmarking...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Micromics Technologies LLC for the development of an "Integrated Platform for In-Depth Single-Cell Proteomics". The contract has a performance period from September 13, 2021 to June 12, 2022 and a ceiling value of $455,000. It is a firm fixed-price definitive contract set aside for small businesses. The original...